These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2701236)

  • 1. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
    Pawlik B; Liber Z; Warzyńska R
    Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occurrence and the sensitivity to drugs of fungi other than Candida albicans isolated from the vagina].
    Pawlik B; Liber Z; Jurkowska E
    Med Dosw Mikrobiol; 1989; 41(1):60-6. PubMed ID: 2668661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro].
    Pospisil J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of Candida kefyr (C. pseudotropicalis) in reproductive tract infections].
    Pawlik B; Jodłowska V
    Med Dosw Mikrobiol; 1992; 44(1-2):83-8. PubMed ID: 1297040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vulvovaginal mycoses].
    Mendling W
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):175-9. PubMed ID: 9606884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.
    Fodor E; Dósa E; Nagy A; Nagy E; Ferenczy L
    Acta Microbiol Immunol Hung; 2002; 49(1):59-68. PubMed ID: 12073826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium].
    Gültekin B; Yazici V; Aydin N
    Mikrobiyol Bul; 2005 Jul; 39(3):319-24. PubMed ID: 16358491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the antifungal effect of a new propiconazole derivative against 64 yeast strains isolated from vaginal mycosis].
    Mareş M; Stefanache A; Popovici I; Valica V; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):768-72. PubMed ID: 18293715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
    Ellabib MS; ElJariny IA
    Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fungal diseases of vulva and vagina caused by Candida species].
    Stock I
    Med Monatsschr Pharm; 2010 Sep; 33(9):324-33; quiz 335-6. PubMed ID: 21192442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vulvovaginal candidiasis: a therapeutic approach].
    Battaglia F; Mariani L; Anglana F; Milite V; Quattrini M; Plotti F; Tomao F; Plotti G
    Minerva Ginecol; 2005 Apr; 57(2):131-9. PubMed ID: 15940073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.